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ABSTRACT
Trinucleotide exchange (TriNEx) is a method for gen-
erating novel molecular diversity during directed
evolution by random substitution of one contiguous
trinucleotide sequence for another. Single trinucleo-
tide sequences were deleted at random positions in
a target gene using the engineered transposon
MuDel that were subsequently replaced with a ran-
domized trinucleotide sequence donated by the DNA
cassette termed SubSeq
NNN. The bla gene encoding
TEM-1 b-lactamase was used as a model to demon-
strate the effectiveness of TriNEx. Sequence analy-
sis revealed that the mutations were distributed
throughout bla, with variants containing single,
double and triple nucleotide changes. Many of the
resulting amino acid substitutions had significant
effects on the in vivo activity of TEM-1, including
up to a 64-fold increased activity toward ceftazidime
and up to an 8-fold increased resistance to the inhi-
bitor clavulanate. Many of the observed amino acid
substitutions were only accessible by exchanging at
least two nucleotides per codon, including charge-
switch (R164D) and aromatic substitution (W165Y)
mutations. TriNEx can therefore generate a diverse
range of protein variants with altered properties by
combining the power of site-directed saturation
mutagenesis with the capacity of whole-gene muta-
genesis to randomly introduce mutations through-
out a gene.
INTRODUCTION
Protein engineering has provided crucial insights into pro-
tein structure, function and folding, and has been pivotal
in adapting proteins for various biotechnological applica-
tions (1). Initial protein engineering strategies focused on
site-directed mutagenesis but due to our limited under-
standing of the complex and cooperative network of
weak interactions that comprise a functional protein, it
is still diﬃcult to predict the consequence of a mutation.
To overcome these diﬃculties, a new approach was taken
that mimicked the natural process of Darwinian evolution
and has been termed directed evolution (2–4). Directed
evolution involves generating molecular diversity by the
introduction of random mutations within a gene followed
by selection of desirable protein variants. Unlike site-
speciﬁc mutagenesis, directed evolution does not require
a detailed knowledge of protein structure or have any
preconceptions of the importance of certain residues to
stability and function. This evolutionary protein engineer-
ing strategy has been very successful in generating proteins
with new properties, with beneﬁcial mutations observed at
positions distant from those predicted to be crucial for
generating novel activity (5,6).
Although a variety of methods exist to introduce pre-
dominantly single point mutations randomly throughout
a whole gene, their limitations include: error, codon and
ampliﬁcation biases, sampling of a restricted set of amino
acids, the masking of beneﬁcial mutations by deleterious
ones and the inability to sample many of the potential
variants due to large and undeﬁned library sizes (7,8).
Some of these problems can be overcome by site-satura-
tion mutagenesis, in which diversity is incorporated into a
synthetic oligonucleotide. However, this approach inherits
the problems of site-directed mutagenesis and mutations
are restricted to just a small portion of the protein.
A new method called trinucleotide exchange (TriNEx) is
proposed that will overcome the limitations of current
methods for generating molecular diversity. TriNEx is a
non-PCR-based method that combines the power of
whole-gene random mutagenesis with the ability of oligo-
nucleotide-directed mutagenesis to sample an expanded
range of amino acid substitutions. Based on a recently
developed transposon method for generating single
amino acid deletion variants (9), TriNEx involves ﬁrst
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then its replacement with a randomized sequence
(Figure 1). This potentially allows the sampling of every
codon permutation throughout a gene and deﬁnes library
diversity and sampling requirements. This method will
overcome the error and codon bias inherent in methods
such as error-prone PCR and will not be restricted to
mutating predeﬁned amino acid residues as is the case
with oligonucleotide-directed mutagenesis. There are no
PCR steps involved in diversity generation so avoiding
any ampliﬁcation bias. Also, as one transposon is inserted
per gene, each variant will contain either a single amino
acid or two adjacent substitutions per protein variant,
preventing the masking of beneﬁcial mutations by other,
distant deleterious mutations. Furthermore, it allows
directed evolution to be applied in a similar manner to
the powerful site-directed single substitution scanning
mutagenesis methods (e.g. alanine scanning mutagenesis)
to assess the contribution of individual amino acid resi-
dues to the structure, function and folding of proteins.
Here, we demonstrate the TriNEx method using the bla
gene encoding TEM-1 b-lactamase. TEM-1 is one of the
main enzymes responsible for conferring bacterial resis-
tance to b-lactam antibiotics such as ampicillin but has
poor activity towards third generation cephalosporins
such as ceftazidime and can be inhibited by clavulanate
(10). We successfully generated libraries with triplet
nucleotide exchanges present throughout the bla gene.
The resulting amino acid substitutions had a range of
eﬀects on the in vivo activity of TEM-1, including
increased activity towards ceftazidime (CAZ) and
improved resistance to clavulanate (CLV). Many of the
amino acid substitutions observed were only accessible
by two or more adjacent nucleotide changes.
MATERIALS AND METHODS
Constructionof libraries withMuDel
inserted randomly within thebla gene
The initial small-scale library (termed BLA
175) that con-
tained 175 variants with MuDel inserted randomly within
the bla gene was a subset of 391 variants generated pre-
viously (11). Construction of the larger, extended library
(termed BLA
1644) comprised of 1644 variants with
MuDel inserted randomly within bla was performed essen-
tially as described previously for the single amino acid
deletion procedure (9,11). The details of this procedure
are described in Supplementary Methods.
Constructionof library containing SubSeq
NNN
randomly placed within bla
The SubSeq
NNN cassette was constructed using PCR as
described in Supplementary Methods. The library of
variants with SubSeq
NNN placed within bla was generated
by the excision of MuDel from the plasmid followed by
the insertion of the SubSeq
NNN DNA cassette. The pooled
DNA (1mg) from either the BLA
175 or BLA
1644
libraries was digested with MlyI to remove MuDel.
The cleaved DNA was then treated with APex
TM heat-
labile alkaline phosphatase (Epicentre Biotechnologies,
Madison, WI, USA) for 15min at 378C. After inactivation
of the phosphatase by heating to 708C for 10min, the
linearized pNOM DNA was separated by agarose gel elec-
trophoresis and puriﬁed. Linear pNOM was ligated with
SubSeq
NNN in 1:3 molar ratio (pNOM:SubSeq
NNN)
using the Fast-Link
TM DNA ligation kit (Epicentre
Figure 1. Schematic outline of the TriNEx procedure. Stage 1.
Trinucleotide deletion. The MuDel library is generated by in vitro trans-
position of the engineered transposon MuDel (teal) into the target DNA.
Restriction endonuclease digestion removes MuDel from this library
together with 3bp of the original target DNA to generate a single break
per molecule. Stage 2. Trinucleotide replacement. The DNA cassette
termed SubSeq
NNN (red) is then inserted between the break in the target
DNA togeneratetheSubSeq
NNNlibrary.The lastthreenucleotides atone
endofSubSeq
NNN(redsquare)arerandomized(NNN).Restrictionendo-
nuclease digestion removes all SubSeq, except for the NNN sequence that
is now incorporated into the target DNA, which replaces the 3bp deleted
in stage 1. Intramolecular ligation regenerates the complete gene contain-
ing new and randomly placed trinucleotide segments. This is followed by
selection and/orscreeningtoidentify newvariants withdesiredproperties.
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the ligation.
With regards to the BLA
175 library, ca 15ng of the
DNA from the ligation reaction was used to transform che-
mically competent Escherichia coli DH5a cells. The trans-
formed cells were grown on LB agar containing 15mg/ml
kanamycin (Kan) and incubated at 378C for 16h. Colonies
were picked at random and used to inoculate 5ml of LB
brothcontaining15mg/ml Kan. PlasmidDNAwas isolated
from each culture using the QIAprep Spin Miniprep kit
(Qiagen Ltd, Crawley, UK). SubSeq was removed from
the plasmid (ca 2mg per 50ml reaction volume) by digestion
with MlyI. The plasmid (ca 20ng) was recircularized
directly after digestion using T4 DNA ligase (Promega
UK, Southampton, UK). An equivalent of ca 0.4ng of
DNA from the ligation reaction was used to transform
chemically competent E. coli DH5a. Half of the cells were
thenspreadonLBagarcontaining32mg/mlAmpandincu-
batedat378Cforaminimumof16h.Theblagenesequence
and the Amp MIC for clones producing active TEM-1 var-
iants were determined as described subsequently. The bla
gene prior to SubSeq removal was also sequenced for sev-
eral inactive variants to predict the mutation that resulted
in loss of b-lactamase activity.
With regards to the BLA
1644 library, the ligation reac-
tion to insert SubSeq
NNN within linearized pNOM was
then used to transform (ca 15ng of DNA/transformation)
high eﬃciency chemically competent NovaBlue E. coli cells
(Merck KGaA). To calculate the number of transformed
cells containing the pNOM-SubSeq
NNN plasmid, the
equivalent of 1/30 of the transformation mix post-recovery
was grown on LB agar plates containing 25mg/ml Kan and
the number of colony forming units (c.f.u.) observed after
incubation at 378C overnight was determined (routinely
generated ca 4 10
5c.f.u./mg DNA). The remainder of
the transformation culture was added to 50ml of LB
broth containing 200mg/ml Kan and incubated at 378C
for 16h. Plasmid DNA was isolated from the culture
using the QIAprep Spin Miniprep kit (Qiagen), and 2mg
of this DNA was digested with MlyI to remove the SubSeq
section. The DNA was desalted and 100ng of the DNA
ligated using the Fast-Link
TM DNA ligation kit
(Epicentre Biotechnologies) to recircularize pNOM. The
ligation reaction (10ng/transformation) was used to trans-
form high eﬃciency chemical competent NovaBlue E. coli
(Merck KGaA, Merck Chemicals Ltd, Nottingham, UK).
Selection ofTEM-1 variants with enhanced activity
towards ceftazidime and clavulanate
Transformed cells were diluted 10-fold in SOC medium
then spread on LB agar containing at least 0.3mg/ml
CAZ or 100mg/ml Amp and 4mg/ml CLV. The plates
were incubated at 378C for a minimum of 16h. Cells trans-
formed with pNOM containing wild-type bla did not grow
under these CAZ and CLV selection conditions. Selected
colonies were transferred to LB broth containing the equi-
valent concentration of antibiotic used in the selection.
The cultures were grown overnight at 378C and glycerol
added to a ﬁnal concentration of 25% (v/v) for storage
at  808C.
Characterization ofthe blatrinucleotide exchange variants
The bla gene of selected variants was isolated by PCR
using the GoTaq system (Promega) with primers ﬂank-
ing the gene (50-TCCGCTCATGAGACAATAACCCTG-
30 and 50-CTACGGGGTCTGACGCTCAGTG-30) and
the PCR product sequenced (DNA Sequencing Core,
Molecular Biology Unit, Cardiﬀ University) to determine
the position and nature of the mutation. The in vivo activity
of the selected variants was estimated by measuring the
minimum inhibitory concentration (MIC) of Amp, CAZ
or Amp and CLV that prevented cell growth. The Amp
MIC values for cells producing TEM-1 variants derived
from the BLA
175 library was determined essentially as
described previously (9,11) and detailed in the Supple-
mentary Methods. The CAZ or CLV+Amp MIC values
of the selected TEM-1 variants derived from BLA
1644
were estimated as follows. The glycerol stocks generated
above were used to inoculate LB broth cultures that were
incubated at 378C for 4h. Each culture was then trans-
ferred, using a 96 pronged replicating fork, to LB agar
containing 0.15, 0.3, 0.6, 1.2, 2.4, 4.8, 9.6, 19.2 or 38.4mg/
ml CAZ, or 2, 3, 4, 6, 8, 12, 16, 32, 64mg/ml CLV with
100mg/ml Amp and the plates incubated at 378C for 16h.
Four colonies containing pNOM were used as controls.
The bla gene was isolated by PCR and sequenced, as
described earlier.
RESULTS
Creationoftrinucleotide substitutionvariants fromBLA"
175
The replacement of one contiguous trinucleotide sequence
with another was achieved in a two-stage process, as out-
lined in Figure 1. The ﬁrst stage involved the removal of a
trinucleotide sequence from a target gene using a pre-
viously described method based on the use of the engi-
neered transposon MuDel (9). The next stage involves
the replacement of the deleted trinucleotide by the inser-
tion of the DNA cassette termed SubSeq
NNN into the
break within the target gene vacated by MuDel. The
mechanism by which trinucleotide deletion and replace-
ment is accomplished is described in Figure 2.
Initially, TriNEx was demonstrated using asubset of 175
variants, constructed previously (11), with MuDel inserted
at random positions within bla. This library was termed
BLA
175 and MlyI digestion from a DNA pool comprised
of the 175 variants removed MuDel. After insertion of
SubSeq
NNN by ligation and transformation of E. coli, plas-
midDNAwasisolatedfromatotalof106diﬀerentcolonies
resistant to Kan and SubSeq removed by digestion with
MlyI. Recircularized plasmid was used to transform
E. coli, and bacterial resistance to Amp tested by plating
on LB agar containing 32mg/ml Amp. Of these 106, viable
cell growth (typically 10–500 colonies per plate) was
observed for 73 with no colony growth detected for the
remaining 33. Of the 73 bla variants capable of conferring
Amp resistance, 34 were sequenced to determine the muta-
tionsintroducedandtoassesstheirinﬂuence ontheMICof
Amp that prevented cell growth. To conﬁrm that variants
unable to confer resistance were a consequence of
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and not gene frameshifts or trinucleotide deletions, 15 of
the 33 bla variants that encoded a TEM-1 variant unable to
confer Amp resistance were sequenced prior to SubSeq
NNN
removal and the TriNEx predicted.
Sequence analysis revealed that the position of the muta-
tions were distributed throughout the bla gene (Figure 3),
with 14, 45 and 41% of the variants containing single,
double or triple nucleotide changes, respectively. No
wild-type or trinucleotide deletion variants of bla were
observed, and no secondary mutations were seen. Two var-
iants were predicted to introduce frameshifts. Each of the
49 variants was unique at the genetic level and only two
were identical at the protein level (Table 1), which both
reconstituted a gene encoding wild-type TEM-1 but with
silent mutations within diﬀerent codons (encoding R120
and L193-L194). The nature of the replacement NNN
sequence could be determined exactly for 33 variants, and
revealed that 27 were unique with no NNN sequence repre-
sented more than twice. Of the 45 variants that encoded
amino acid substitutions, mutation of six residues were
observed twice and one three times. However, the tri-
nucleotide replaced was not always the same (Table 1).
For example, Q278W was generated by exchange of three
nucleotides 1bp upstream of those replaced to produce
Q278C. At least 88% of the MuDel insertion positions
predicted from the sequence data were judged to be
unique, close to that observed previously (11). Just over
half (26 from 45) of the TEM-1 variants contained amino
acid substitutions only accessible by mutation of at least
two of the three nucleotides.
Exchange of contiguous trinucleotide segments can span
two adjacent codons in theoretically 2/3 of cases, poten-
tially leading to a double amino acid substitution. Due to
the degeneracy in the genetic code and mutation of either
one or two nucleotides, the majority of variants (66%)
encoded a single amino acid substitution (Table 1), with
just under a half of these (15 from 31) containing a silent
mutation.
The in vivo activity of TEM-1 variants also varied
depending on the mutation, with Amp MIC conferred
on E. coli ranging from 64mg/ml (e.g. E274P) to
4096mg/ml (e.g. Q205R and Q278W) observed for wild-
type TEM-1 (Table 1). Of the 15 variants that displayed
no TEM-1 activity, three were predicted to contain sub-
stitutions that generated a stop codon (e.g. K192ter) and
another disrupted the initiation codon (M1N-S2G). Many
of the other predicted mutations could be classed as poten-
tially disruptive to TEM-1 structure and/or function. The
M69R-S70C mutation knocks out the essential catalytic
serine. Mutation of C77 in the core helix of TEM-1
will remove the sole disulphide bond in the protein.
Others may disrupt organized secondary structure
Figure 2. Mechanism of TriNEx process. Step 1. Two MlyI recognition sites (50GAGTC(N)5#) were placed 1bp from each end of MuDel, 1bp away
from the site of transposon insertion. MlyI cuts 5bp outside its recognition sequence to generate a blunt end. Insertion of MuDel results in the duplication
of 5bp (N1N2N3N4N5) of the target gene at the insertion point (23,24). Step 2. Digestion with MlyI removes MuDel together with 8bp of the target
DNA (4bp at each end). This equates to removal of a contiguous 3bp sequence from the starting target gene (N2N3N4). Step 3. SubSeq
NNN is then ligated
into the gap vacated by MuDel. SubSeq
NNN also contains two MlyI recognition sites strategically placed towards the ends of the cassette. One site is
located so that MlyI will cut at the exact point where the target DNA joins SubSeq
NNN. The second site will cut 3bp into SubSeq
NNN so donating 3bp
(NXNYNZ) to the target DNA. Step 4. Digestion with MlyI removes SubSeq but with 3bp of its sequence now replacing the 3bp deleted from the target
gene. Step 5. Intramolecular ligation reforms the target gene but with one contiguous trinucleotide sequence replaced with another.
Figure 3. Position andnumberof nucleotides changes introduced intothe
39 bla TriNEx variants derived from BLA
175. The grey, orange and
green triangles signify 1, 2 and 3 nucleotide replacements, respectively.
The black triangles represent frameshifts due to deletion of two nucleo-
tides from bla.
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the hydrophobic core close to the active site (e.g.
A135D-N136Y). TEM-1 has also been shown previously
not to tolerate mutations as positions T181 or G251 (12).
Two variants were predicted to contain frameshifts due to
the removal of two nucleotides from the bla gene (Table 1)
but no trinucleotide deletions were predicted. However, it
cannot be ruled out that errors introduced post SubSeq
removal and the subsequent self-ligation stages were
responsible for inactivation of some of the TEM-1
variants.
Construction ofan extended TriNEx library and
theselection of enhanced TEM-1 variants
The main aim of directed evolution is the creation and
sampling of a suitable range of molecular diversity to
alter or improve proteins. As a demonstration of the ability
of TriNEx to fulﬁl this aim, it was employed to improve the
activity of TEM-1 towards a third generation cephalos-
porin CAZ, and enhance resistance to the inhibitor CLV.
First, a much larger transposon insertion library was
required to sample all the potential insertion positions
within bla. A new library comprised of 1644 Amp sensitive
colonies was constructed with MuDel inserted within bla
and was termed BLA
1644. The size of this library was
deemed suﬃcient to cover all potential insertion positions
withinbla(codingregionof858bp),evenwhenredundancy
in transposon insertion positions [10–15%; see above and
reference (11)] is factored in. The diversity of transposon
insertion was conﬁrmed using a restriction endonuclease
procedure described previously (Figure 4a) (11). The diges-
tion products form a smear, as would be expected if MuDel
insertion within bla was essentially random (Figure 4b).
The BLA
1644 members were pooled and MuDel removed
by digestion with MlyI and SubSeq
NNN ligated into the
break. Transformation of E. coli with the ligation mixture
routinely generated ca 4 10
5c.f.u./mg of DNA on agar
plates containing Kan. This was deemed suﬃciently high
to sample the possible 54 912 diﬀerent genetic variations of
bla that can be generated by TriNEx, if every possible con-
tiguous trinucleotide sequence is replaced (gene size of 858
multiplied by 64 diﬀerent NNN combinations). The trans-
formed cells were subsequently grown under a stringent
Kan selection regime (200mg/ml) to ensure that only cells
containing plasmid-borne SubSeq
NNN would survive.
DNA was then isolated from the culture to generate a plas-
mid pool of SubSeq
NNN inserted at random positions
within bla.
The SubSeq portion was removed by MlyI digestion
and the plasmid pool recircularized. This formed the
library used for the selection of TEM-1 variants with
improved properties. Minimum estimates of 41000 var-
iants were tested under each condition to select those cap-
able of promoting cell growth on 0.3mg/ml CAZ or a
combination of 100mg/ml Amp and 4mg/ml CLV.
However, this was probably an underestimate because in
the absence of a second selectable marker, the calculation
was based on the number of colonies observed on LB agar
plates containing 100mg/ml Amp. While the majority of
TEM-1 substitution variants were likely to retain even a
low level of activity towards Amp, the previous results of
individual TEM-1 variants derived from BLA
175 indi-
cated that 31% would be inactive. Using this as a guide,
the number of variants screened under each selection
Table 1. Sequence variation observed in bla variants derived from the
BLA
175 library and their inﬂuence on TEM-1 activity towards Amp
in vivo
Amino acid
substitutions
a
Nucleotide
substitutions
b
Base
changes
c
Amp MIC
(mg/ml)
d
Wild type    4096
M1N-S2G atg agt!aat ggt 3N G
R9V cgt!gtt 2 512
D38E-Q39P gat cag!gaa ccg 2 256
L40ter ttg ggt!tga tgt 3N G
G41S ggt!agt 1 4096
N52K-S53A aac agc!aag gcc 3 1024
M69R-S70C atg agc!agg tgc 2N G
L76L C77R cta tgt!cta cgt 1N G
C77P tgt!cca 3N G
A79V gcg!gta 2 2048
V103V E104G gtt gag!gtc ggg 2 2048
V103V E104L gtt gag!gtg ctg 3 1024
S106T tca!acc 2 256
S106C tca!tgt 2 256
P107A cca!gct 2 256
T114T D115Y acg gat!acc tat 2N G
M117I atg!ata 1 1024
T118M-V119I aca gta!atg ata 3 512
R120R aga!agg 1 4096
C123ter tgc agt!tga tgt 2N G
A125G-A126S gct gcc!gga tcc 36 4
T128T M129G acc atg!act ggg 3 512
A135D-N136Y gcc aac!gat tac 3N G
M155S-G156W atg ggg!agt tgg 36 4
M155I-G156Q atg ggg!att cag 3 1024
M155I-G156E atg ggg!atc gag 2 1024
P167P E168L ccg gag!cct ttg 3 1024
T181D acg!gac 3N G
R191R K192ter cgc aaa!cgt taa 2N G
L193L-L194L cta tta!ctc cta 2 4096
L194C-T195P tta act!tgt cct 3N G
R204R Q205R cgg caa!cgc cga 2 4096
W210 fs gac tgg atg – NG
!ga––ac atg
A213G gcg!ggt 2 4096
P226P A227T ccg gct!cca act 2 4096
S235 fs tct gga!tcg ––a –N G
L250H-G251R ctg ggg!cac agg 3N G
L250L G251R ctg ggg!cta cgg 2N G
R259I cgt!atc 3 256
T266K-G267S acg ggc!aag agc 2 512
Q269L cag!ctg 1 4096
M272R atg!agg 1 512
D273D E274Q gat gaa!gac caa 2 2048
E274P gaa!cca 26 4
R277R Q278W aga cag!agg tgg 3 4096
Q278C cag!tgt 3 2048
A280A E281S gct gag!gcg tcg 3 2048
I282T ata!acc 26 4
K288N-H289V aag cat!aac gtt 3 512
aSubscripted sequences represent silent nucleotide changes to the
codon. fs represent frameshift. Residues numbered according to stan-
dard system (25).
bBold and underlined sequences represent the known nucleotides
deleted from bla and replaced by SubSeq
NNN.
cActual number of nucleotide diﬀerences between the variant and wild-
type bla.
dNG, no cell growth observed on 32mg/ml Amp LB agar upon removal
of SubSeq and reconstitution of the full length bla.
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wild-type TEM-1 (via the parent pNOM plasmid) did not
grow at these CAZ or Amp+CLV concentrations. A total
of 408 or 93 colonies were observed to grow on LB agar
under either the CAZ or Amp+CLV selection conditions,
respectively. Of these, 41 colonies selected on CAZ and
27 selected on Amp/CLV were arbitrarily chosen for
sequencing and in vivo activity analysis (Table 2 and full
list in Supplementary Table 1).
CharacterizationofTEM-1variantswithimprovedproperties
Analysis of the TEM-1 variants with enhanced activity
towards CAZ and increased resistance to CLV revealed a
range of substitution mutations at diﬀerent positions instil-
lingvariousdegrees ofimprovementoverwild-type TEM-1
(Table 2 and Supplementary Table 1). Many of the best
performing TEM-1 variants had amino acid substitutions
only accessible by at least two nucleotide changes per
codon. These included the charge-switch mutant R164D
with a 32-fold improvement in activity towards CAZ and
the semi-conservative aromatic substitution of tryptophan
to tyrosine (W165Y), which increased CLV resistance
3-fold (Table 2). The R275V mutation common to variants
with the most improved resistance to CLV also required at
least two adjacent nucleotide changes to access the amino
acid substitution (Table 2). The importance of residue 164
to improving resistance to CAZ (10) was also highlighted
here as 30 of the analysed variants were mutated at this
residue, with six diﬀerent substitutions observed
(Supplementary Table 1).
Beneﬁcial eﬀects of two adjacent amino acid mutations
were also observed. For example, there was up to a 4-fold
improvement in the CAZ MIC values for variants contain-
ing the W165G mutation when accompanied by R164P
(Table2andSupplementaryTable1).TheR164Pmutation
was only observed in combination with a substitution at
W165. This highlights the advantages of sampling such
adjacent mutations. In other cases, the adjacent mutation
had little eﬀect. For example, the CAZ MIC value for var-
iants containing the P167H mutation was similar to those
that contained the accompanying E168K substitution
(Table 2). The use of diﬀerent codons to specify mutations
also appeared to inﬂuence the in vivo activities of TEM-1 in
some cases (Table 2 and Supplementary Table 1). For
example, the R164P-W165R variants were encoded by
ﬁve diﬀerent gene sequences but their CAZ MIC values
varied 4-fold. It has been noted previously that silent muta-
tions to TEM-1 can also result in such diﬀerences (13,14).
The majority of beneﬁcial mutations occurred close to
the active site (Figure 5), of which several were to residues
that had previously been identiﬁed as important in enhanc-
ing activity to CAZ (e.g. R164S and R164H) and resistance
Figure 4. Restriction endonuclease analysis of the BLA
1644 library. (a) Rationale for determining MuDel (teal) insertion diversity within the bla
gene (orange with black stripe) of pNOM. Digestion by XhoI (recognition site shown as blue triangle) of the pooled pNOM plasmid with MuDel
inserted within the bla gene generates one major product of 3422bp in size. Digestion with MlyI (recognition site shown as red triangle) generates
two major products of 1310bp (MuDel plus 8bp from bla) and 2112bp in size. Digestion with both XhoI and MlyI generates the 1310bp MuDel
fragment together with many diﬀerent size fragments depending on the insertion position of the transposon. (b) Restriction analysis of the BLA
1644
library with XhoI and/or MlyI, as indicated in the ﬁgure.
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and references therein]. Beneﬁcial mutations included a
run of eight substitutions (six consecutively between 163
and 168) in the V-loop (Figure 5). This unexpectedly
included three independent variants with enhanced activity
to CAZ that had the catalytically important E166 mutated.
One mutation, E197P, was relatively distance from the
active site (Figure 5) but slightly enhanced activity towards
CAZ and resistance to CLV (Table 2). This highlights
the power of directed evolution to sample mutations
not predicted to be beneﬁcial by structural analysis, and
the ability of TriNEx to expand mutational sampling
(E!P requires substitution of at least two adjacent
nucleotides).
DISCUSSION
TriNEx as amethodfor generating molecular diversity
Directed evolution has been proven as an eﬀective strategy
for engineering proteins (2–6). Critical to directed evolu-
tion is the ability to generate and sample molecular diver-
sity. While whole-gene mutagenesis methods such as
error-prone PCR (15) are relatively simple to perform
and can introduce mutations throughout a given target
DNA sequence, they can only sample a restricted muta-
tional range (with inherent biases) and generate large
libraries of which only a fraction can ever be sampled
(8). Site-saturated mutagenesis using oligonucleotide-
encoded molecular diversity overcomes the limited muta-
tional range of whole-gene mutagenesis but is restricted to
sampling just a few residue positions in a protein so
requires a detailed knowledge of the structure–function
relationship to predict which residues to target.
TriNEx attempts to overcome these problems by pro-
viding a useful alternative that combines the beneﬁts of
both approaches. The random insertion and deletion
(RID) method (16) was also developed to overcome simi-
lar problems but this method is diﬃcult to implement
(including the requirement of single strand DNA) and
uses PCR. Furthermore, many variants contained second-
ary mutations and frameshifts that reduce the quality of
the library. TriNEx does not use PCR at any stage during
library construction and utilizes simple DNA manipula-
tion and microbiological methods familiar to most mole-
cular biologists. Only two frameshifts were predicted and
no secondary point mutations or trinucleotide deletions
were observed in the sequenced clones produced by
TriNEx (Tables 1 and 2, Supplementary Table 1).
TriNEx has been successfully demonstrated using the
bla gene encoding TEM-1 b-lactamase as our test
system. The observed mutations were distributed through-
out bla, with the majority of the variants containing 2- or
3-bp changes with respect to wild-type (Figure 3 and
Tables 1 and 2). Many of the resulting amino acid sub-
stitutions introduced into TEM-1 could only be accessed
by more than 1 bp change to a codon. Therefore, TriNEx
can expand the molecular diversity sampled by whole-gene
mutagenesis procedures to introduce novel amino acid
substitutions that may enhance the properties of a protein.
The ﬁrst transposon step ultimately determines TriNEx
library diversity. MuDel is based on the mini-Mu trans-
poson, which has a reported 5-bp target site for insertion
based on the consensus sequence 50 N-Py-G/C-Pu-N
30 (17). Such a sequence bias may result in hotspots for
Table 2. Examples of TEM-1 variants with enhanced properties in vivo
a
Amino acid
substitution
b
Nucleotide changes MIC fold change
c
CAZ CLV
M69I atg!atc   3
P145R ccg!cga 4  
D163E-R164N gat cgt!gag aat 16  
D163D R164S gat cgt!gac tct 32  
D163D R164H gat cgt!gac cat 64  
D163D R164D gat cgt!gac gat 32  
R164P-W165R cgt tgg!cct agg 32  
cgt tgg!ccg cgg 4  
R164P-W165G cgt tgg!cca ggg 8  
W165G tgg!ggg 2  
W165P tgg!cct   2
W165Y tgg!tac   3
tgg!tat   3
E166G gaa!gga 8  
P167H ccg!cac 8  
E171P gaa!cca 8  
R178A cgt!gca 4  
E197P gaa!cca 2 1.5
G238G E240R ggt gag!ggc agg 4  
S243S R244T tct cgc!tcc acc   3
R275V cga!gta   8
cga!gtg   8
cga!gtt   8
R275T cga!acc   2
aThe full list of sequenced TEM-1 variants are shown in Supplementary
Table 1.
bNumbering according to standard system (25).
cFold change compared to MIC observed for cells producing wt
TEM-1 encoded in the pNOM plasmid (CAZ MIC 0.3mg/ml, CLV
MIC 4mg/ml).
Figure 5. Position of mutations with respect to the tertiary structure of
TEM-1 [PDB code 1BTL (18)]. Mutations that enhance activity to
CAZ or CLV or both are shown as cyan, orange or purple balls,
respectively. The active site serine (S70) is shown as space-ﬁll and
labelled. The V-loop is coloured red. The residues are numbered
using the recommended numbering system (25).
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library. While some duplication of the trinucleotide
sequences deleted in separate variants derived from the
BLA
175 library was observed (Table 1), the general
redundancy of transposon insertion positions was esti-
mated to be 10–15%. This agrees with previously observed
redundancy but in a diﬀerent mutational context (11).
Restriction analysis of the BLA libraries reported both
here (Figure 4) and previously (11) conﬁrm the random
nature of MuDel insertion position. Therefore, the diver-
sity of insertion positions sampled by MuDel allows muta-
tions to be distributed throughout bla. A diverse range of
replacement NNN encoded as part of SubSeq
NNN was
also observed (Table 1).
Insertion of MuDel outside of the target gene within the
plasmid backbone may also be an issue. This was over-
come here by selection for clones resistant to Cam but
sensitive to Amp due to the knockout of bla by MuDel
insertion. Using linear DNA comprised solely of the target
gene can overcome this problem. It has been demonstrated
previously that linear DNA acts as an eﬃcient substrate
for transposon insertion (17). While recloning the target
gene back into pNOM after transposition may reduce the
eﬃciency of the ﬁrst step in the procedure, the subsequent
selection for Cam resistance will result in theoretically
100% of clones containing MuDel inserted within the
target gene. This is particularly important when applying
TriNEx to proteins in which there is no simple selection or
screen available. We have recently demonstrated this strat-
egy, along with other approaches, in our laboratory to
implement TriNEx for non-antibiotic resistance proteins
(data not shown).
The number of variants that can be generated at each
stage is also critical to the ability of TriNEx to sample a
suitable range of diversity. The generation of 1644 variants
withMuDelinsertedwithinthe858bpblagenewasdeemed
more than suﬃcient even when taking into account redun-
dancy in transposon insertion. Blunt-end ligations akin to
that necessary for the insertion of SubSeq
NNN can be less
eﬃcient than those performed with compatible overhangs,
which may potentially reduce the number of subsequent
variants sampled. The blunt-end ligation of SubSeq
NNN
into bla routinely generated 4 10
5 Kan resistant colonies
per microgram of DNA after transformation, which was
considered high enough to sample the potentially 54912
diﬀerent potential genetic variations of bla. The ﬁnal recir-
cularization ligation to reform the trinucleotide replace-
ment bla gene variants was extremely eﬃcient, routinely
producing ca 10
7c.f.u./mg DNA. Therefore, TriNEx can
generate a suitable number of variants at each stage to
sample an extensive range of molecular diversity for a
single and, if required, multiple iterative rounds where the
target gene may be comprised of several diﬀerent variants
selected from the previous round of TriNEx.
As TriNEx can span two codons in theoretically
2/3 of
cases, this can and does lead to substitution mutations in
two adjacent amino acid residues (Table 1). Of the 49
sequenced variants derived from BLA
175, 30 were
known to contain trinucleotide exchanges that spanned
two codons (Table 1), yet only 14 encoded a double
amino acid substitution. Due to the degeneracy in the
genetic code many of the mutations were silent at the pro-
tein level. The result is that 66% of the variants contained a
single amino acid substitution. Furthermore, sampling
such double substitutions may not be consider detrimental
but may enhance diversity. For example, a 4-fold increase
in TEM-1 activity towards CAZ was observed when
W165G was combined with R164P (Table 2).
Mutations introduced by TriNEx alter
the activity ofTEM-1
TriNEx introduced a wide variety of amino acid substitu-
tions into TEM-1 with varying eﬀects on the enzyme’s
in vivo activity (Tables 1 and 2). Many of the TEM-1 var-
iantsderivedfromBLA
175retainedahighdegreeofactiv-
ity, with eight (including the two with wild-type amino acid
sequence) of the 34 active variants conferring an Amp MIC
value similar to that of wild-type. Interestingly, these
included mutations to residues generally conserved in
class A b-lactamases (10) or not consider tolerant to a sub-
stitution (12) (e.g. P107, A125, G156, M272 and I282). As
69% of the tested variants derived from BLA
175 library
retained even a small degree of b-lactamase activity
towards Amp, this conﬁrms previous work (12) that sug-
gests TEM-1 is largely tolerant to amino acid substitutions.
TriNEx has also been successfully employed to improve
the activity of TEM-1 towards the third generation cepha-
losporin CAZ and increase resistance to the inhibitor CLV.
Most of these mutations lay within or close to regions
involved in the catalytic process and substrate binding
(Figure 5). Many of the beneﬁcial mutations were observed
in the V-loop (residues 163–178 (18)). This included sub-
stitution of the catalytically important E166 (to glycine or
lysine) observed in three independent clones that improved
TEM-1 activity towards CAZ by up to 8-fold (Table 2 and
Supplementary Table 1). A variety of substitutions to R164
were observed in many of the variants with improved activ-
ity towards CAZ, including those with highest observed
activity (Table 2 and Supplementary Table 1). Mutations
to R164 have been demonstrated previously to improve
activity towards CAZ by removing a salt bridge that con-
strains conformation of the V-loop (10,19). To our knowl-
edge, some of the speciﬁc mutations to R164 identiﬁed in
this study (to asparagine, aspartate and proline) have not
been observed previously. Mutations outside the V-loop
also contribute towards enhanced activity towards CAZ.
These include some novel mutations such as P145R and
P145R-K146E that lie close to both the catalytic centre
and the V-loop (Figure 5).
TriNEx also introduced mutations to residues known to
contribute to improved resistance to CLV (M69, W165,
R244 and R275) (10). Mutations at these positions are
thought to alter substrate binding, including for suicide
substrates such as CLV. Mutations to R275 produced
the largest improvements, with the R275V substitution
increasing resistance by 8-fold (Table 2). Natural variants
of TEM-1 resistant to CLV contain either a leucine or
glutamine at residue 275 and are found in combination
with other beneﬁcial mutations [(10) and www.lahey.org/
Studies/]. The ability of TriNEx to expand the mutational
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tion observed in our study had such a drastic eﬀect alone.
One TEM-1 variant containing the E197P mutation dis-
played a slightly enhanced activity towards CAZ and
resistance to CLV. Its potential mode of action is unclear
as it is distant from the active site and to our knowledge
has not been observed before. The fact this particular
substitution required the exchange of 2bp of the E197
codon may explain why it has not been observed in nat-
ural or engineered variants of TEM-1. However, the rela-
tively small enhancements may not have been suﬃcient to
overcome previous selection pressures.
SUMMARY
We have successfully demonstrated that TriNEx can gen-
erate a diverse range of proteins with altered properties.
Although the exchange of contiguous trinucleotide
sequences has been demonstrated here, the method has
the potential to allow the exact replacement of a codon
with a deﬁned sequence. This will be useful for implement-
ing scanning mutagenesis or extending directed evolution
to allow incorporation of artiﬁcial amino acids (e.g.
encoded by the amber stop codon) in vivo at random posi-
tions within a protein (20). The basic method also provides
a novel approach for creating integral fusion proteins that
have the potential to act as novel molecular switches by
replacing SubSeq
NNN with a DNA cassette encoding a pro-
tein domain (21,22). These applications are currently being
explored.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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